Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)
NCT00163436
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Ciclesonide
Sponsor
AstraZeneca